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INTRODUCTION 
 
  The Ames/Salmonella assay, developed by Professor Bruce Ames at the University of 
California, Berkeley, is a rapid and sensitive assay for detecting mutagenicity of various 
chemical compounds  (Maron and Ames, 1983).  It is a widely accepted short-term assay 
for detecting chemicals that induce mutations in the histidine (his) gene of Salmonella 
typhimurium.  This is a reverse mutation assay that detects the mutational reversion of 
his-dependent Salmonella to the his-independent counterpart.  Thereby, mutagenic 
compounds will increase the frequency of occurrence of his-independent bacterial 
colonies. The assay utilizes the specific genetically constructed strains of bacteria either 
with or without mammalian metabolic activation enzymes (S9), Aroclor induced rat liver 
homogenate) to assess the mutagenicity of different compounds. In this study, we will 
use the Ames/Salmonella assay to investigate the mutagenicity of Hexanitrostilbene 
(HNS) from both Bofors and Pantex, and Dipicryethane (DPE). 
 
MATERIALS AND METHODS   
  
Chemicals  
  The Atomic Weapons establishment in the UK provided us with HNS from Bofors and 
Pantex, and DPE was obtained from BWXT Pantex, LLC.  Dimethylformamide (DMF), 
the solvent used to dissolve the compounds, was obtained from J.T. Baker Chemical Co.. 
All other chemicals and bacteriological media were of best quality from standard sources. 
.  
Bacterial strains 
  Salmonella typhimurium strains TA98 and TA100 were kindly provided by Dr. Bruce 
Ames (University of California, Berkeley, CA). TA98 is sensitive to frameshift inducing 
mutagens, whereas TA100 to base substitution inducing mutagens. 
  Salmonella typhimurium strain YG1024 was a generous gift of Dr. T. Nohme (National 
Institute of Heath Sciences, Tokyo).  YG1024 is a derivative of S. typhimurium TA98 
with a high expression level of O-acetyltransferase activity (Watanabe et al. 1990) in 
addition to its sensitivity to the frame-shift inducing mutagens. 
 
Mutation assay 
   The Microsuspension plating method (Kado et al., 1983) was used to evaluate the 
mutagenicity of HNS and DPE.  It is a highly sensitive plating method for testing the 
mutagenicity of pure chemicals available only in small amounts.  The mutation assay is 
briefly described.  Bacteria were grown overnight in Oxoid Nutrient Broth No.2 to 
approximately 109 bacteria/ml and harvested by centrifugation  (5000 x g, 4 °C, 10 min).  
The pellet was washed once in cold phosphate –buffered saline  (PBS, 0.15M, pH7.4) and 
resuspended in ice-cold PBS at a final concentration of 1x1010 bacteria/ml (10-fold 
concentration).  The assay tube consisted of 0.1 ml of the concentrated bacteria, 0.1 ml of 
PBS and different concentrations of the tested compound.  The volume of the tested 
compound added should not exceed 20µl.  From our study, we found that these 
compounds did not require metabolic activation.  Therefore, S9 was not added.  The 
mixture was then incubated for 90 min at 37°C with constant mixing at 120 rpm.  Next, 2 
ml of molten top agar was added immediately to the incubated mixture and poured onto 
the minimal glucose agar plates.  The plates were incubated for 48 hr at 37° C.   Bacterial 
colonies were scored using the Artek Counter, model 888 (Imaging Products 
International, Chantilly, Virginia). 
 
RESULTS, DISCUSSION 
 
Preliminary requirements were investigated before the study. The mutagenicity of DMF, 
used for dissolving HNS and DPE, was evaluated in the Ames Assay. A different amount 
of DMF was tested using bacteria TA98 with and without metabolic activation (S9) 
shown in Fig.1.  The numbers of revertants per plate from both conditions were similar to 
that of DMSO, which was used as background controls in our laboratory.  Therefore, 
DMF was not mutagenic in the Ames assay. HNS from Bofors and Pantex were dissolved 
in DMF at 10 mg/600µl and 10mg/800µl, respectively. DPE was dissolved in 
10mg/200µl of DMF 
                                                                 Fig.1  
 
  To establish the best plating method, we compared the Microsuspension and 
Preincubation plating methods (Zeiger and Mortelmans, 1999).  The mutation potency of 
HNS (Pantex) in TA98 with Microsuspension and Preincubation plating method was 
5467 revertants/mg, 1130 revertants, respectively. The mutation potency of HNS in 
Microsuspension plating method was four-fold more potent than that of the Preincubation 
method.  Therefore, the Microsuspension plating method was used for all subsequent 
mutation studies of the three compounds. 
  The requirement of metabolic activation (S9) was studied in HNS from both Bofors and 
Pantex shown in Fig. 2A and 2B below.  Since bacteria lack most of the mammalian 
enzymes necessary for metabolic activation, an external supply of these enzymes (S9) 
was added.  Our study showed both compounds were mutagenic with dose response 
sensitivity.  However, the metabolic activation did not play a significant role in the 
mutagenic response indicating these compounds were direct mutagens. Therefore, S9 was 
not required for the study of these compounds  
 
 
                       Fig. 2A                                                                        Fig. 2B 
 
  In the Ames assay, each chemical was subjected to three strains of bacteria, TA98, 
TA100 and YG1024 without metabolic activation.  For each experiment, a positive 
control containing standard diagnostic mutagens specific for each bacteria strain, and also 
a solvent control showing revertants from background spontaneous mutagenesis were 
included. 
   For each chemical, the dose-response curve was generated from a minimum of four 
dose points in replicates of two. Each experiment was repeated two or three times.  The 
final summary was the average of these experiments, and was presented graphically as 
dose-response curve. The mutagenic profile of each chemical was expressed as 
mutagenic potency.  Mutagenic potency was expressed as the revertant colonies/mg of 
the tested compound. It was calculated from the linear portion of the dose-response 
curve. Additionally, the arbitrary two-fold rule (Cariello and Piegosch, 1996; Glatt and 
Meinl, 2004) can also be used to seek out the mutagenicity of the compound. Using this 
rule, a positive response requires a dose-response that reaches at least 2- fold over the 
background spontaneous revertants. 
   Fig. 3 illustrated the dose-response curve of HNS (Bofors), HNS (Pantex) and DPE 
with TA 98.  They were all mutagenic with dose-response sensitivity with HNS (Pantex) 
being the most potent followed by HNS (Bofors) and DPE.  The mutagenic profile can be 
concluded as HNS (Pantex) >HNS (Bofors) >DPE, and in accordance with the mutagenic 
potency calculation (Table 1) and the arbitrary two-fold rule. 
                                                                                               
 
 
 
                                                      Fig.3 
 
   Fig. 4 illustrated that in bacteria YG1024, all compounds showed a clear dose-
dependent positive response, with HNS (Pantex) being the most mutagenic.  The dose 
response curves of HNS (Bofors) and DPE were almost identical.  The mutagenic 
potency of all three compounds was significantly higher than that shown by TA98. As 
previously mentioned, YG1024 was a derivative of TA98 and with a high expression 
level of O-acetyltransferase activity in addition to its sensitivity to the frame-shift 
inducing mutagens. Watanabe et al. (1993) demonstrated that YG1024 was highly 
sensitive to the mutagenic actions of N-hydroxyarylamines derived from aromatic amines 
and nitroarenes.  Since all these compounds belonged to the class of nitroarenes, their 
mutgenicity were further enhanced by the activation of O-acetyltransferase (Glatt and 
Meinl, 2004).  As a result, their mutagenic potencies were also higher than that shown by 
TA98. 
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   In TA100 (Fig.5), the mutagenic responses of both HNS were very weak. The 
mutagenic potencies of HNS (Bofors) and HNS (Pantex) were 400 and 414, respectively 
(Table 1), and the fold increase over the spontaneous revertants was less than two-fold. 
Therefore, they were not base substituting inducing mutagens.  DPE, with a mutagenic 
potency of 1316, and a 2.3 fold increase over the spontaneous revertants, was a weak 
base-substitution inducing mutagen.  
 
 
                                               Fig. 5 
 
    In the Ames assay, all three compounds show good dose-response sensitivity in TA98, 
YG1024 and TA100.   They are direct mutagens without the need of metabolic activation.  
Based upon the mutagenic potency (Table 1), we conclude that the mutagenic profile of 
these compounds are as follows; TA 98, HNS (Pantex) > HNS (Bofors) > DPE; YG1024, 
HNS (Pantex) > HNS (Bofors) >DPE; TA100, DPE > HNS (Pantex) > HNS (Bofors).  
Among the three compounds, HNS (Pantex) is the most potent mutagen in both TA98 
and YG1024.  They are all frame-shift inducing mutagens due to their strong mutagenic 
response in TA98 and YG1024, and not base-substitution due to their negligible and 
weak response in TA100. 
   When the mutagenic potencies of these three compounds are compared to that of the 
food derived heterocyclic amine mutagens such as IQ and PhIP, they are not as potent.  
With TA98, the mutagenic potency is 194,000/µg for IQ, and 1700/µg for PhIP.  With 
the same strain, the mutagenic potencies for HNS (Bofors), HNS (Pantex) and DPE are 
2456/mg, 5467/mg, 1192/mg, respectively. From our study, we can conclude that HNS 
from both Bofors and Pantex, and DPE  belong to the class of frame-shift inducing 
mutagens.  
 
 
 
 
Table 1 
Bacteria Compounds Mutagenic Potency 
(revertants/mg. of 
compound) 
TA98 HNS (Bofors)  2456 
 HNS (Pantex) 5467 
 DPE 1192 
   
YG1024 HNS (Bofors)  6388 
 HNS (Pantex) 16453 
 DPE 6060 
   
TA100 HNS (Bofors)  400 
 HNS (Pantex) 414 
 DPE 1316 
Mutation potency is calculated as revertans minus spontanoues revertants (obtained from the linear 
regression dose curve) divided by the concentration of the compound. 
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